CLINICAL / SCIENTIFIC PRESENTATION AND PUBLICATION HIGHLIGHTS

The information contained in each post on this page was factually accurate on the date it was issued and posted. 

IGCS 2020 Annual Global Meeting – Abstract

Phase 1 Dose-Escalation Study of STRO-002, an anti-Folate Receptor alpha (FRα) Antibody Drug Conjugate (ADC), in Patients with Advanced Platinum Resistant/Refractory Epithelial Ovarian Cancer (OC). Dr. Naumann is currently the Director of Minimally Invasive Surgery in...

read more
Sutro Biopharma, Inc.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.